Anti-tumor necrosis factor-alpha therapy for refractory uveitic optic disk neovascularization in active non-infectious posterior and panuveitis.
Radgonde AmerOren CohenPublished in: International ophthalmology (2021)
Our results suggest that targeting TNF-α achieves long-term control of uveitic NVD refractory to conventional treatments.